Simultaneous toxicities in a child on multiple anticonvulsants

Area of Science:

• Pediatric Neurology
• Clinical Toxicology
• Pharmacology

Background:

• Anticonvulsant medications are frequently prescribed for pediatric epilepsy.
• Polypharmacy with multiple anticonvulsants, including valproic acid, lamotrigine, and phenytoin, is common.
• Simultaneous drug toxicities are uncommon but can be severe.

Observation:

• A 3.5-year-old child on a regimen of valproic acid, lamotrigine, and phenytoin developed concurrent hepatotoxicity and bone marrow toxicity.
• The patient experienced a parainfluenza virus type 3 infection during the onset of these toxicities.
• Seizures were managed with lorazepam while anticonvulsants were discontinued.

Findings:

• The combination of valproic acid, lamotrigine, and phenytoin may be associated with simultaneous hepatotoxicity and bone marrow toxicity.
• Concurrent viral infections, such as parainfluenza virus type 3, might potentiate the risk of these adverse drug reactions.
• Discontinuation of the anticonvulsant regimen led to the resolution of both toxicities.

Implications:

• Clinicians should be vigilant for rare, simultaneous toxicities in pediatric patients on multiple anticonvulsants.
• The potential for drug-drug and drug-infection interactions increasing toxicity risk warrants consideration.
• This case highlights the importance of careful monitoring and prompt management of adverse events in pediatric epilepsy treatment.